Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Patricia Sánchez Jiménez"'
Autor:
Ancor Sanz-García, Patricia Sánchez-Jiménez, Inmaculada Granero-Cremades, María De Toledo, Paloma Pulido, Marta Navas, Jose Maria Frade, Desirée Pereboom, Cristina Virginia Torres-Díaz, María Carmen Ovejero-Benito
BackgroundEpilepsy is one of the most prevalent neurological diseases, a third of patients remain drug-resistant. The exact etiology of drug-resistant epilepsy (DRE) is still unknown. Neural tetraploidy has been associated with neuropathology. The ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a713cd482341570c47ee7d689578fa0e
https://doi.org/10.1111/nan.12873
https://doi.org/10.1111/nan.12873
Autor:
Patricia Sánchez-Jiménez, Marcos Elizalde-Horcada, Ancor Sanz-García, Inmaculada Granero-Cremades, María De Toledo, Paloma Pulido, Marta Navas, Ana Beatriz Gago-Veiga, Lola Alonso-Guirado, María Concepción Alonso-Cerezo, Desirée Nava-Cedeño, Francisco Abad-Santos, Cristina Virginia Torres-Díaz, María C. Ovejero-Benito
Publikováno v:
Molecular neurobiology.
Epigenetic changes such as DNA methylation were observed in drug-resistant temporal lobe epilepsy (DR-TLE), a disease that affects 25-30% of epilepsy patients. The main objective is to simultaneously describe DNA methylation patterns associated with
Autor:
Patricia Sánchez Jiménez, Marcos Elizalde-Horcada, Ancor Sanz-García, Inmaculada Granero-Cremades, María De Toledo, Paloma Pulido, Marta Navas, Ana Beatriz Gago-Veiga, Lola Alonso-Guirado, María Concepción Alonso-Cerezo, Desirée Nava-Cedeño, Francisco Abad-Santos, Cristina Virginia Torres-Díaz, María Carmen Ovejero-Benito
Epilepsy is a disabling neurological disease that affects 2% of the population. Drug-resistant epilepsy (DRE) affects 25-30% of epilepsy patients. Understanding its underlying mechanisms is key to adequately manage this condition. To analyze the main
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0272211216f0b3f8f16e4045bc620636
https://doi.org/10.1101/2022.03.14.22271975
https://doi.org/10.1101/2022.03.14.22271975
Autor:
Antonio Gómez Martín, Marcos Elizalde Horcada, María C. Ovejero-Benito, Gemma Benito, Javier Fraga, Marta Navas, Paolo Maietta, Francisco Abad-Santos, NIMGenetics Genómica y Medicina S.L., Madrid, Spain, Inmaculada Granero-Cremades, Paloma Pulido, Cristina V. Torres, María de Toledo, Francisco Abad Santos, Patricia Sánchez-Jiménez
Publikováno v:
IBJ Plus.
Autor:
María C Ovejero-Benito, Francisco Abad-Santos, Ancor Sanz-García, Alejandra Reolid, Mar Llamas-Velasco, L. Alonso‐Guirado, J. García‐Martínez, Esteban Daudén, Patricia Sánchez-Jiménez, Ester Muñoz-Aceituno
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 35
Autor:
Dolores Ochoa, Alejandra Reolid, Patricia Sánchez-Jiménez, Miriam Saiz-Rodríguez, Samuel Martín-Vílchez, Mar Llamas-Velasco, Ester Muñoz-Aceituno, Esteban Daudén, María C Ovejero-Benito, Manuel Román, Teresa Cabaleiro, Francisco Abad-Santos
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Introduction] Epigenetic factors play an important role in psoriasis onset and development. Biological drugs are used to treat moderate-to-severe psoriasis patients resistant to conventional systemic drugs. Although they are safe and effective, some